Caricamento...

Treatment and management of myelofibrosis in the era of JAK inhibitors

Myelofibrosis (MF) can present as a primary disorder or evolve from polycythemia vera (PV) or essential thrombocythemia (ET) to post-PV MF or post-ET MF, respectively. MF is characterized by bone marrow fibrosis, splenomegaly, leukoerythroblastosis, extramedullary hematopoiesis, and a collection of...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Keohane, Clodagh, Radia, Deepti H, Harrison, Claire N
Natura: Artigo
Lingua:Inglês
Pubblicazione: Dove Medical Press 2013
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3753053/
https://ncbi.nlm.nih.gov/pubmed/23990704
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/BTT.S34942
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !